Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04IRR
|
||||
Former ID |
DNC003049
|
||||
Drug Name |
Ly231514 Tetra Glu
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551393] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H35N7O12
|
||||
Canonical SMILES |
C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)NC<br />(CCC(=O)NC(CCC(=O)O)C(=O)O)C(=O)O)C(=O)O
|
||||
InChI |
1S/C30H35N7O12/c31-30-36-24-23(26(43)37-30)16(13-32-24)6-3-14-1-4-15(5-2-14)25(42)35-19(29(48)49)8-11-21(39)33-17(27(44)45)7-10-20(38)34-18(28(46)47)9-12-22(40)41/h1-2,4-5,13,17-19H,3,6-12H2,(H,33,39)(H,34,38)(H,35,42)(H,40,41)(H,44,45)(H,46,47)(H,48,49)(H4,31,32,36,37,43)/t17-,18-,19-/m0/s1
|
||||
InChIKey |
DVABISOQQNSPJW-FHWLQOOXSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Thymidylate synthase | Target Info | Inhibitor | [551393] | |
BioCyc Pathway | Pyrimidine deoxyribonucleotides biosynthesis from CTP | ||||
Pyrimidine deoxyribonucleotides de novo biosynthesis | |||||
Superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis | |||||
Superpathway of pyrimidine deoxyribonucleoside salvage | |||||
DTMP de novo biosynthesis (mitochondrial) | |||||
Pyrimidine deoxyribonucleosides salvage | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
PathWhiz Pathway | Pyrimidine Metabolism | ||||
WikiPathways | Trans-sulfuration and one carbon metabolism | ||||
Retinoblastoma (RB) in Cancer | |||||
One Carbon Metabolism | |||||
Integrated Pancreatic Cancer Pathway | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in leukocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
Metabolism of nucleotides | |||||
Fluoropyrimidine Activity | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.